Brazil's Bio-Manguinhos Institute Still in Bidding Process for Oxford's COVID-19 Vaccine Production, an Industrial Info Market Brief

The Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Institute of Technology in Immunobiology Bio-Manguinhos) in Brazil has just started the bidding process for its $127 million project for fill-and-finish production of Oxford's COVID-19 vaccine. The vaccine is still in the clinical human trials stage, but conclusive results are expected before the end of the year.

The Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos has a production plant in Rio de Janeiro, Brazil, and $356 million in projects in Industrial Info's project database. Click here for a list, and see below for a breakdown by project type.